Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsAssociation of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot studyReview article: Infliximab therapy for inflammatory bowel disease--seven years onCystic fibrosis and Crohn's disease: successful treatment and long term remission with infliximab.A randomized controlled trial of growth hormone in active pediatric Crohn disease.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Growth problems in children with IBD.Infliximab therapy in pediatric Crohn's disease: a review.Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritisImpact of Inflammatory Bowel Disease upon Growth in Children and Adolescents.Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody.Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis.Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α AntibodiesControl of systemic and local inflammation with transforming growth factor beta containing formulas.Managing complicated Crohn's disease in children and adolescents.Growth retardation in pediatric Crohn's disease: pathogenesis and interventions.Mathematical modelling to restore circulating IGF-1 concentrations in children with Crohn's disease-induced growth failure: a pharmacokinetic study.Infliximab therapy for pediatric Crohn's disease.Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel diseaseEarly Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants.Update on nutritional status, body composition and growth in paediatric inflammatory bowel disease.The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.Antitumor necrosis factor treatment for pediatric inflammatory bowel disease.Medical therapy for pediatric inflammatory bowel disease.Mucosal healing in Crohn's disease: a systematic review.Advances in the medical management of paediatric IBD.Endocrine therapy for growth retardation in paediatric inflammatory bowel disease.The Role of Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease.Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients.The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature.Steroid Administration and Growth Impairment in Children with Crohn's Disease.Targeting mucosal healing in Crohn's disease.Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort.Anti-tumor necrosis factor α prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn's disease.Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy.Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.Association of height with inflammation and periodontitis: the Study of Health in Pomerania.Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target.Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn's Disease Patients.
P2860
Q22242050-591E808F-FC25-4A2E-8204-E360A73D5D97Q24630823-9EEA4976-DD43-4761-A6C4-A0D65935C564Q28294134-7E7DE738-30E0-4C31-9B10-73DD02E5EB7FQ33798912-78162300-EBFE-475E-8061-3B98FD435D6CQ34023206-151646DA-75CF-487F-B3FE-3F624944B620Q34152778-5667E38C-2ABC-449A-B33C-AE4700D8BD37Q34426164-5D1FF3C7-485F-4FA3-A0D9-966B7D1AF4C4Q35026358-13168C18-0C73-4DBF-BA17-4EF29624B8B7Q35637479-8D2E3268-D298-4227-A416-BF8A3DEF8C7CQ35687352-D5157DE7-8E37-4094-948F-77771C69EE56Q35692293-760345E5-0968-439F-BB7C-E68EF648FC91Q35761249-2B488772-17CB-4474-88F5-BCAC3C77265AQ36135544-1497123D-A73F-4475-BAF9-7CE57B2EF103Q36175761-5A10F69E-D743-41F2-8321-8CB5B6587EDFQ36331225-6BBEFF02-1DA4-4034-A283-8E2573FCCCD9Q36722112-53B9E066-61F8-418C-B208-4041938B7045Q36876580-7A969596-4916-4BE2-80E1-05446AE76086Q37012073-6AE474AA-3CC8-4984-BC3D-C1D2456B0EA5Q37223169-7D57C90B-5DE0-4FE4-8F0D-9290F44533ABQ37609746-2E1ABEE2-0D80-4139-971C-BBCD238C05A7Q37629942-82117039-95F1-42E6-B28B-5D8E958E5688Q37660677-265AB924-591C-4E81-AADE-FDBE1022FBCFQ37820898-1DD88ADD-DE4A-49A0-8835-84D8E768982DQ37936394-BFE6552A-589B-4C2A-A8CE-29A861096D3BQ37986622-4A8D9CB7-58F3-47B7-9BA8-782E455FF5D9Q38005972-AC7EE81C-22C4-4591-8F3F-774E73CDB104Q38130044-955AB084-41D4-41EA-952B-93E62164A25FQ38137812-3A65EC00-1335-423D-9669-218CA6EF0A91Q38568813-427AFBFF-F99F-49F4-A6CF-19CE3AD6E5EFQ39114030-D180A64A-48BF-4B4E-A662-49AEB16C7F5FQ40113811-D1957FBA-BDBF-47F2-9148-3E3724DF83DDQ40122541-678D1AED-9FAB-4EF2-9E52-3209704AF982Q42857508-CDB7ADEF-31A8-4794-B72E-23087CC70052Q43633425-764F3E18-93B3-4435-9BA6-33049E1359ECQ44132897-7A04353A-7407-4D53-891C-661EB9E3C5ADQ46234832-FD26ED6E-D9B7-44E2-8AB6-8A1B6E83BDDAQ47188554-159FE407-AC90-4093-A2A6-138E06CD829BQ47297535-31A99754-2831-41F0-9516-17CF2B6F628DQ48518781-85B83E0D-A969-49A3-AD61-9E537DA5E236Q49339951-3407A8BF-F4B6-4337-B9E2-DBF9B9BDBD6F
P2860
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Infliximab heals intestinal in ...... children with Crohn's disease.
@en
Infliximab heals intestinal in ...... children with Crohn's disease.
@nl
type
label
Infliximab heals intestinal in ...... children with Crohn's disease.
@en
Infliximab heals intestinal in ...... children with Crohn's disease.
@nl
prefLabel
Infliximab heals intestinal in ...... children with Crohn's disease.
@en
Infliximab heals intestinal in ...... children with Crohn's disease.
@nl
P2093
P1476
Infliximab heals intestinal in ...... children with Crohn's disease.
@en
P2093
Bascietto C
Borrelli O
Bueno de Mesquita M
P304
P356
10.1016/J.DLD.2003.12.014
P577
2004-05-01T00:00:00Z